Approval · Notice of Compliance 22525 · 2019
OPSUMIT: Notice of Compliance 22525
Issued August 12, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22525
- Date
- August 12, 2019
- Company
- Janssen Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Labelling Only
- Reason
- Labelling Update
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OPSUMIT | Not yet assigned | — |
Medicinal ingredients
- MACITENTAN 10 MG per TAB